InvestorsHub Logo
Followers 49
Posts 1993
Boards Moderated 0
Alias Born 11/02/2020

Re: None

Wednesday, 04/03/2024 3:50:57 PM

Wednesday, April 03, 2024 3:50:57 PM

Post# of 21132
Critical analysis of a stinky pinky company is as important as a Nasdaq or NYSE company, if not moreso. Public information actually means something.

This is a small "company" of 2 elderly retired doctors who use their golf course neighborhood outside Las Vegas to peddle human supplements/vitamins through marketing companies they pay royalties to. There is nothing groundbreaking about their stuff compared to the thousands of products on store shelves in reputable brick and mortar stores. They publicly report loss after annual loss. The next report is coming, but late. They publicly checked the box for no significant changes. So, just failed business as usual.

Same with the horse supplement subsidiary. Small sales, big losses. The only real money comes from secondary offerings of near worthless new dilutive shares. The pump before the next annual report has come and gone with newly created bagholders among the smart flippers who took advantage.

Place your bets on whether thier chances are better for quad zeros v. dub zeros. It's right in the sweet spot of half trips. Which way will the pendulum swing after the 10K is filed??? Good Luck!